好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A European consortium for high-profile translational research on early-onset dementia – a prevalence study of the FTLD-ALS causing C9orf72 repeat expansion mutation in an extended European cohort
Aging/Dementia/Degenerative Disease
(-)
010
Authors/Disclosures
No disclosure on file
No disclosure on file
No disclosure on file
Glenn T. Stebbins, PhD (Rush University Medical Center) Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
No disclosure on file
No disclosure on file
Jean-Jacques Martin, MD (Universiteit Antwerpen (formerly)) No disclosure on file
No disclosure on file
Christine Van Broeckhoven, PhD (University of Antwerp - CDE) Dr. Van Broeckhoven has nothing to disclose.
No disclosure on file